1. A Closer Look at the Role of Anti-CCP Antibodies in the Pathogenesis of Rheumatoid Arthritis-Associated Interstitial Lung Disease and Bronchiectasis

   • Tanjila Khan
   • Ricardo J. Jose
   • Maria Mouyis

   Review Open access 27 August 2021 Pages: 1463 - 1475

   

2. Clinical Management of Women with Newly Diagnosed Osteoporosis: Data from Everyday Practice in Bulgaria

   • Mihail A. Boyanov
   • Anna-Maria Borissova
   • Reneta T. Petkova

   Review Open access 06 September 2021 Pages: 1477 - 1491

   

3. Differentiating Psoriatic Arthritis from Osteoarthritis and Rheumatoid Arthritis: A Narrative Review and Guide for Advanced Practice Providers

   • William Saalfeld
   • Amanda M. Mixon
   • Eileen J. Lydon

   Review Open access 14 September 2021 Pages: 1493 - 1517

   

4. Predictors, Risk Factors, and Incidence Rates of Psoriatic Arthritis Development in Psoriasis Patients: A Systematic Literature Review and Meta-Analysis

   • Alen Zabotti
   • Orazio De Lucia
   • Roberto Caporali

   Review Open access 01 October 2021 Pages: 1519 - 1534

   

5. Esophageal Dysfunction in Systemic Sclerosis: An Update

   • Bo Li
   • Junqing Yan
   • Xuan Wang

   Review Open access 09 October 2021 Pages: 1535 - 1549

   

6. Incidence of Infusion Reactions and Clinical Effectiveness of Intravenous Golimumab Versus Infliximab in Patients with Rheumatoid Arthritis: The Real-World AWARE Study

   • Jeffrey R. Curtis
   • Soumya D. Chakravarty
   • Sergio Schwartzman

   Original Research Open access 20 August 2021 Pages: 1551 - 1563

   

7. Treatment Patterns and Resource Utilization of Pregnant Women with Inflammatory Rheumatic Diseases or Psoriasis in Germany: A Claims Database Analysis

   • Katja Blaschke
   • Rebecca Fischer-Betz
   • Ingrid Schubert

   Original Research Open access 24 August 2021 Pages: 1565 - 1584

   

8. Abatacept is Efficacious in the Treatment of Older Patients with csDMARD-Refractory Rheumatoid Arthritis: A Prospective, Multicenter, Observational Study

   • Sei Muraoka
   • Zento Yamada
   • the ABT-ATS study group

   Original Research Open access 26 August 2021 Pages: 1585 - 1601

   

9. Systematic Review and Meta-Analysis of Inflammatory Bowel Disease Adverse Events with Anti-Interleukin 17A Agents and Tumor Necrosis Factor Inhibitors in Rheumatic Disease and Skin Psoriasis

   • Steven L. Truong
   • Jasmine Chin
   • Philip C. Robinson

   Original Research Open access 26 August 2021 Pages: 1603 - 1616

   

10. Knee Osteoarthritis Pain Management with an Innovative High and Low Molecular Weight Hyaluronic Acid Formulation (HA-HL): A Randomized Clinical Trial

    • Alberto Migliore
    • Tomasz Blicharski
    • Jean-Yves Reginster

    Original Research Open access 30 August 2021 Pages: 1617 - 1636

    

11. Biologic and Targeted Synthetic DMARD Utilization in the United States: Adelphi Real World Disease Specific Programme for Rheumatoid Arthritis

    • Elizabeth A. Holdsworth
    • Bethany Donaghy
    • Daniel E. Furst

    Original Research Open access 02 September 2021 Pages: 1637 - 1649

    

12. Occurrence of Possible Rheumatologic Immune-Related Adverse Events (rh-irAEs) Associated with Immune Checkpoint Inhibitor (ICI) Therapy

    • Suzanne Anjohrin
    • Anna Sheahan
    • Victor S. Sloan

    Original Research Open access 07 September 2021 Pages: 1651 - 1659

    

13. Identification of a Rule to Predict Response to Sarilumab in Patients with Rheumatoid Arthritis Using Machine Learning and Clinical Trial Data

    • Markus Rehberg
    • Clemens Giegerich
    • the MOBILITY, MONARCH, TARGET, and ASCERTAIN investigators

    Original Research Open access 14 September 2021 Pages: 1661 - 1675

    

14. Articular and Extra-Articular Benefits in ACR20 Non-responders at Week 104 Treated With Apremilast: Pooled Analysis of Three Randomized Controlled Trials

    • Philip J. Mease
    • Dafna D. Gladman
    • Iain B. McInnes

    Original Research Open access 18 September 2021 Pages: 1677 - 1691

    

15. The Risk Factors of Exacerbation in Interstitial Pneumonia With Autoimmune Features: A Single-Center Observational Cohort Study

    • Okinori Murata
    • Katsuya Suzuki
    • Makoto Maemondo

    Original Research Open access 18 September 2021 Pages: 1693 - 1710

    

16. Pharmacokinetics and Safety of Intravenous and Subcutaneous Auto-injector Single-dose Belimumab in Healthy Chinese Volunteers: A phase 1, Randomized, Open-label Study

    • Xianmin Meng
    • Qianqian Wang
    • Hongzhou Lu

    Original Research Open access 23 September 2021 Pages: 1711 - 1724

    

17. Racial Differences in Prevalence and Treatment for Psoriatic Arthritis and Ankylosing Spondylitis by Insurance Coverage in the USA

    • Alexis Ogdie
    • Wesley Matthias
    • Christopher D. Saffore

    Original Research Open access 25 September 2021 Pages: 1725 - 1739

    

18. Exploring the Quality of Communication Between Patients with Psoriatic Arthritis and Physicians: Results of a Global Online Survey

    • Laura C. Coates
    • Valderilio F. Azevedo
    • Samantha Howland

    Original Research Open access 27 September 2021 Pages: 1741 - 1758

    

19. Single and Composite Endpoints of Within-Patient Improvement in Symptoms: Pooled Tanezumab Data in Patients with Osteoarthritis

    • Thomas J. Schnitzer
    • Francis Berenbaum
    • Kenneth M. Verburg

    Original Research Open access 04 October 2021 Pages: 1759 - 1774

    

20. A Pooled Analysis Reporting the Efficacy and Safety of Secukinumab in Male and Female Patients with Ankylosing Spondylitis

    • Irene van der Horst-Bruinsma
    • Corinne Miceli-Richard
    • Effie Pournara

    Original Research Open access 07 October 2021 Pages: 1775 - 1787

    

21. Improvement in Patient-Reported Outcomes in Patients with Psoriatic Arthritis Treated with Upadacitinib Versus Placebo or Adalimumab: Results from SELECT-PsA 1

    • Vibeke Strand
    • Philip J. Mease
    • Dafna D. Gladman

    Original Research Open access 12 October 2021 Pages: 1789 - 1808

    

22. Ultrasound Effectiveness of Steroid Injection for hand Psoriatic Dactylitis: Results from a Longitudinal Observational Study

    • Nicolò Girolimetto
    • Pierluigi Macchioni
    • Francesco Caso

    Original Research Open access 15 October 2021 Pages: 1809 - 1826

    

23. Patient-Reported Outcomes in Psoriatic Arthritis Patients with an Inadequate Response to Biologic Disease-Modifying Antirheumatic Drugs: SELECT-PsA 2

    • Vibeke Strand
    • Filip Van den Bosch
    • Peter Nash

    Original Research Open access 18 October 2021 Pages: 1827 - 1844

    

24. Clinical Characteristics of Psoriatic Arthritis in Chinese Patients: A Cross-Sectional Study

    • Zhibo Song
    • Xuerong Deng
    • Zhuoli Zhang

    Original Research Open access 19 October 2021 Pages: 1845 - 1857

    

25. Significance of Macrophage Subtypes in the Peripheral Blood of Children with Systemic Juvenile Idiopathic Arthritis

    • Dan Feng
    • Wen-Yan Huang
    • Yu-Jie Hu

    Original Research Open access 25 October 2021 Pages: 1859 - 1870

    

26. Post Hoc Biomarker Analyses from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar® Gel) for Persistently Active Systemic Lupus Erythematosus

    • Anca D. Askanase
    • Dale Wright
    • Richard A. Furie

    Brief Report Open access 03 September 2021 Pages: 1871 - 1886

    

27. Antirheumatic Drug Intake Influence on Occurrence of COVID-19 Infection in Ambulatory Patients with Immune-Mediated Inflammatory Diseases: A Cohort Study

    • Debellemanière Guillaume
    • Bouvet Magalie
    • Gatinel Damien

    Brief Report Open access 16 September 2021 Pages: 1887 - 1895

28. MRI Assessment of Extra-axial Findings at Pelvic Sites in a Group of Axial-SpA Patients

    • Fabio Massimo Perrotta
    • Silvia Scriffignano
    • Ennio Lubrano

    Brief Report Open access 20 September 2021 Pages: 1897 - 1904

    

29. Low-Dose Interleukin-2 as an Alternative Therapy for Refractory Lupus Nephritis

    • Xia Zhang
    • Ruiling Feng
    • Jing He

    Brief Report Open access 07 October 2021 Pages: 1905 - 1914

    

30. Correction to: Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

    • Anca D. Askanase
    • Enxu Zhao
    • Richard A. Furie

    Correction Open access 30 August 2021 Pages: 1915 - 1915

31. Correction to: Risk Factors for Progression from Subclinical to Clinical Phase of Psoriatic Arthritis: A Case–Control Study

    • Yiyi Wang
    • Li Ding
    • Wei Li

    Correction Open access 02 September 2021 Pages: 1917 - 1918

32. Correction to: A Closer Look at the Role of Anti-CCP Antibodies in the Pathogenesis of Rheumatoid Arthritis Associated Interstitial Lung Disease and Bronchiectasis

    • Tanjila Khan
    • Ricardo J. José
    • Maria Mouyis

    Correction Open access 27 September 2021 Pages: 1919 - 1919

33. Correction to: Identification of a Rule to Predict Response to Sarilumab in Patients with Rheumatoid Arthritis Using Machine Learning and Clinical Trial Data

    • Markus Rehberg
    • Clemens Giegerich
    • the MOBILITY, MONARCH, TARGET, and ASCERTAIN investigators

    Correction Open access 29 October 2021 Pages: 1921 - 1922